PLAY PODCASTS
Treatment of Skin and Soft Tissue Infections
Episode 296

Treatment of Skin and Soft Tissue Infections

Listen as Kyle Molina, PharmD, BCIDP, discusses guideline recommendations for treatment of both purulent and nonpurulent skin and soft tissue infections, challenges with IV and oral antibiotics, and the role of long-acting lipoglycopeptides in the treatment landscape

Decera Clinical Education Infectious Disease Podcast · Kyle Molina PharmD BCIDP

July 11, 202327m 38s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Kyle Molina, PharmD, BCIDP, provides an overview of treatment of skin and soft tissue infections (SSTIs) and challenges in practice. Listen as he gives perspectives on:

  • Guideline recommendations for treatment of purulent and nonpurulent SSTIs
  • Logistical challenges with IV and oral antibiotics
  • Pros and cons of various locations of care
  • Data supporting the safety and efficacy of long-acting lipoglycopeptides for treatment of SSTIs
  • Use of long-acting lipoglycopeptides in special populations of interest, including patients with obesity, diabetes, and injection drug use
  • Overall place in therapy of long-acting lipoglycopeptides for SSTIs

 

Faculty:

Kyle Molina, PharmD, BCIDP
Infectious Diseases Clinical Pharmacist
Scripps Green Hospital
La Jolla, California

Link to full program: 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

treatmentobesitysstipurulentgroup a streptococciwound infectionallergys. aureusstaphylococciclinical presentationmrsaglycopeptidesseverity classificationantimicrobial stewardshipfurunclelocations of caresolologisticsempiricdur001-303abscessabscesschallengesnonpurulentcarbunclechromeambulatorygroup a streptococcuspkacute bacterial skin and skin structure infectiondiabetesabsssiincision and drainageplace in therapygroup a strepambulatory careskin and soft tissue infectionseverelipoglycopeptidescellulitisoritavancinsystemic inflammatory response syndromemildsafetyerysipelassirsmoderateoral antibioticslength of staypharmacokineticsmajor cutaneous abscessdefinitivei&dantimicrobial prescribingnecrotizing fasciitishospitalizationpatients who inject drugslong-acting lipoglycopeptidesdalbavancinefficacystaphylococcus aureusmssadiscoverstreptococci